NCT07506785 Home-Based Exercise After Cervical Epidural Steroid Injection for Cervical Radiculopathy
| NCT ID | NCT07506785 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Necmettin Erbakan University |
| Condition | Cervical Radiculopathy |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2026-02-01 |
| Primary Completion | 2026-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2026-02-01 with a primary completion date of 2026-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Cervical radiculopathy is a common cause of neck and arm pain resulting from compression or inflammation of a cervical nerve root. Cervical epidural steroid injection is frequently used to reduce pain and improve function in patients who do not respond to conservative treatment. However, long-term functional recovery may require additional rehabilitation strategies. This randomized controlled trial aims to investigate whether adding a standardized home-based exercise program after cervical interlaminar epidural steroid injection improves pain, disability, sleep quality, and quality of life in patients with chronic cervical radiculopathy. Participants will be randomly assigned to receive either injection alone or injection followed by an eight-week home-based exercise program.
Eligibility Criteria
Inclusion Criteria: * Age between 18 and 70 years. * Chronic cervical radicular pain lasting ≥3 months, characterized by neck pain with accompanying arm pain consistent with a cervical nerve root distribution. * Average pain intensity ≥4/10 on the Numeric Rating Scale (NRS) over the preceding 7 days at baseline. * Diagnosis of chronic cervical radiculopathy due to cervical disc herniation, confirmed by clinical examination and cervical MRI findings at the corresponding level. * Insufficient response to conservative treatment, including physical therapy, medication, and/or exercise therapy. * Ability to provide written informed consent and comply with study procedures. Exclusion Criteria: * Patients were excluded if any of the following were present: * Clinical signs of cervical myelopathy or progressive neurological deficit. * Suspicion of serious spinal pathology (e.g., infection, malignancy). * Contraindications to epidural steroid injection, including uncontrolled coagulopathy, anticoagulant therapy not appropriately managed, or local/systemic infection. * Pregnancy. * Prior cervical spine surgery or cervical epidural steroid injection within the prespecified washout period. * Severe musculoskeletal or neurological comorbidities that could interfere with safe participation in the exercise program. * Discordance between clinical symptoms and imaging findings.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07506785 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Cervical Radiculopathy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07506785 currently recruiting?
Yes, NCT07506785 is actively recruiting participants. Contact the research team at baydogan.g@gmail.com for enrollment information.
Where is the NCT07506785 trial being conducted?
This trial is being conducted at Konya, Turkey (Türkiye).
Who is sponsoring the NCT07506785 clinical trial?
NCT07506785 is sponsored by Necmettin Erbakan University. The trial plans to enroll 60 participants.